Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma has submitted a routine quarterly certificate from its Registrar and Share Transfer Agent (Bigshare Services Private Limited) to the stock exchanges, as required under SEBI Regulation 74(5). The certificate confirms that no dematerialisation requests (requests to convert physical share certificates into electronic/demat form) were received from shareholders during the quarter from 1st April 2025 to 30th June 2025. This is a standard procedural compliance filing, signed by the Company Secretary and Compliance Officer on 8th July 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that no shareholder converted physical shares into demat form during the quarter, indicating that essentially all shares are already held in dematerialised form.